Cencora (COR) Cash from Investing Activities (2009 - 2026)
Cencora (COR) reported Cash from Investing Activities of -$4.9 billion for Q1 2026, down 19.55% on a YoY basis from -$6.1 billion in Q1 2025, and down 1528.69% quarter-over-quarter from -$299.3 million in Q4 2025.
Cencora (COR) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Cencora has reported Cash from Investing Activities for 18 years, with the latest figure at -$4.9 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 19.55% year-over-year to -$4.9 billion; the trailing twelve-month figure through Mar 2026 stood at -$5.7 billion (down 19.23% YoY), and the FY2025 full-year result was -$5.0 billion, down 705.26% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$4.9 billion, down from -$299.3 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $143.5 million in Q2 2022, with the low at -$4.9 billion in Q1 2026.
- Historically, Cash from Investing Activities has averaged -$799.8 million across 5 years, with a median of -$234.7 million in 2025.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities jumped 102.54% — and 2025, when it plunged 2349.21%.
- Cencora's Cash from Investing Activities stood at -$1.5 billion in 2022, then soared by 95.65% to -$65.8 million in 2023, then slumped by 421.34% to -$343.0 million in 2024, then advanced by 12.75% to -$299.3 million in 2025, then slumped by 1528.69% to -$4.9 billion in 2026.
- The last three Cash from Investing Activities figures came in at -$4.9 billion (Q1 2026), -$299.3 million (Q4 2025), and -$321.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 425.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -4.87 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -181.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | -63.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 53.93 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -754,000.00 |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -3.21 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -708,963.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.87 Bn |
| Mar 31, 2026 | -4.87 Bn |
| Dec 31, 2025 | -299.32 Mn |
| Dec 31, 2025 | -299.32 Mn |
| Sep 30, 2025 | -321.94 Mn |
| Sep 30, 2025 | -321.94 Mn |
| Jun 30, 2025 | -234.69 Mn |
| Jun 30, 2025 | -234.69 Mn |
| Mar 31, 2025 | -4.08 Bn |
| Mar 31, 2025 | -4.08 Bn |
| Dec 31, 2024 | -343.04 Mn |
| Dec 31, 2024 | -343.04 Mn |
| Sep 30, 2024 | -241.89 Mn |
| Sep 30, 2024 | -241.89 Mn |
| Jun 30, 2024 | -143.92 Mn |
| Jun 30, 2024 | -143.92 Mn |
| Mar 31, 2024 | -166.49 Mn |
| Mar 31, 2024 | -166.49 Mn |
| Dec 31, 2023 | -65.80 Mn |
| Dec 31, 2023 | -65.80 Mn |